Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General business news Nassau Financial Group, Golub Capital forge strategic partnership with $200m investment Nassau Financial Group (“Nassau”), renowned for its fixed annuities and asset management services, and Golub Capital, a leader… byPallavi MadhirajuJune 3, 2024